Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph I/II Nivolumab in comb w/ Lenalidomide in relapsed/refractory NHL and HD

Protocol: OSU-16167

Full Title

A Phase I/II Study of the PD-1 Antibody Nivolumab in combination with Lenalidomide in relapsed/refractory Non-Hodgkin’s Lymphoma (NHL) and Hodgkin’s Disease (HD)

For More Information

See Full Trial at ClinicalTrials.gov
Email This Trial to Your Physician to Verify Eligibility
Print a Copy of This Trial
Learn More About Clinical Trial Phases
Protocol Page (Login Required)
Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell) Hodgkin’s Lymphoma

Related News

June 23, 2017

In the Defense of Science

Darrell Ward has spent his career explaining the complexities and awesomeness of science to a wide audience of people. It’s an important mission, and one that has become even more vital.

June 22, 2017

What Men Should Know About Testicular Cancer

Testicular cancer occurs most often in young and middle-aged men, but can be diagnosed in males of any age – from infant to elderly.

June 21, 2017

From Bench to Bedside: Understanding How Cancer Research Becomes Cancer Treatment

Groundbreaking discoveries are made in the labs of the world-class cancer researchers of the OSUCCC – James. But, it takes a long time to get this research from development to treating patients.

More News
More Blog Posts